Dechra Pharmaceuticals PLC operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dechra Pharmaceuticals PLC with three other
pharmaceutical manufacturers in Europe:
Dottikon ES Holding AG
sales of 174.77 million Swiss Francs [US$189.14 million]
of which 100%
was The pharmaceutical),
(£260.00 million [US$330.79 million]
Allergy Therapeutics PLC
(£78.20 million [US$99.50 million]
Dechra Pharmaceuticals PLC reported sales of £515.10 million (US$655.34 million)
June of 2020.
increase of 6.9%
versus 2019, when the company's sales were £481.80 million.
Sales at Dechra Pharmaceuticals PLC have increased during each of the previous five years
(and since 2015, sales have increased a total of 153%).
Sales of Na Pharmaceuticals saw an increase
7.8% in 2020, from
£177.80 million to £191.60 million.